Health Trials

REGistry of Long-term AnTithrombotic TherApy-2

ConditionAtrial Fibrillation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNational Medical Research Center for Cardiology, Ministry of Health of Russian Federation

About this trial

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation

Eligibility criteria

Qualifiers

Documented atrial fibrillation with CHA2DS2VASC > 1

Disqualifiers

Subjects who are unwilling or unable to provide informed consent. ACS within 12 months before inclusion Severe CHF (NYHA IV) Stroke within 6 months before inclusion Severe liver or muscle disease Severe kidney disease / renal failure with creatinine > 3 mg/dl Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention

Trial design

Treatments tested in this trial

  • Anticoagulants

Treatment groups

No treatment groups listed

Sponsors and collaborators

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Lead sponsor

Source ClinicalTrials.gov